Chronic Mesenteric Ischemia: Clinical Diagnosis, Imaging Characteristics, and Endovascular Management

2018 ◽  
Vol 02 (03) ◽  
pp. 217-222
Author(s):  
Leonard Dalag ◽  
Jonathan Lorenz ◽  
Thomas Tullius

AbstractChronic mesenteric ischemia (CMI) is a complex disorder, which typically affects elderly patients who classically present with longstanding abdominal pain and nonspecific clinical symptoms, such as food aversion and weight loss. The disease progression is often gradual due to a rich collateral network, and symptoms are generally not clinically apparent until two or more primary visceral arteries are affected. Symptomatic stenosis or occlusion of the mesenteric arteries can be the result of multiple etiologies, although atherosclerosis is the most common. Given its low incidence, a high clinical suspicion is necessary for diagnosis and to prevent a delay in treatment. Multiple imaging modalities are utilized to confirm the presence of mesenteric vessel involvement and to guide treatment. While open surgical revascularization was once the definitive treatment, endovascular management has become the first-line treatment for atherosclerotic CMI. The endovascular approach with stent placement has shown excellent primary success and encouraging long-term outcomes with reduction in morbidity and mortality compared with open surgical revascularization. Although controversial, median arcuate ligament syndrome (MALS) is a less common cause of CMI, which can affect a more varied patient population. Clinical approach, imaging characteristics, and treatment for this syndrome will also be discussed.

2015 ◽  
Vol 18 (5) ◽  
pp. 219
Author(s):  
Ali Ihsan Parlar ◽  
Seyhan Babaroglu ◽  
Muhammet Onur Hanedan ◽  
Mehmet Ali Yürük ◽  
Salih Fehmi Katircioglu

<strong>Background:</strong> Chronic mesenteric ischemia and carotid stenosis frequently have coexistent coronary artery disease. Myocardial ischemia is the most common cause of morbidity and mortality following revascularization of the peripheral arteries. The optimal treatment of concurrent mesenteric, carotid, and coronary disease is unknown. <br /><strong>Case Report:</strong> We report a case of a 75-year-old man who required revascularization of the left anterior descending coronary and superior mesenteric arteries and carotid endarterectomy. After concomitant surgical revascularization, the patient remained asymptomatic during the 3-year follow-up. <br /><strong>Conclusion:</strong> A good result in this case encourages us for one-stage combined surgical intervention in patients who require multisystem revascularization.


2015 ◽  
Vol 49 (1-2) ◽  
pp. 37-44 ◽  
Author(s):  
Mahmud Saedon ◽  
Athanasios Saratzis ◽  
Ahmed Karim ◽  
Steve Goodyear

2011 ◽  
Vol 1 (1) ◽  
pp. 2 ◽  
Author(s):  
Eva Schönefeld ◽  
Susanne Szesny ◽  
Konstantinos P. Donas ◽  
Georgios A. Pitoulias ◽  
Giovanni Torsello

The authors would present the mid-term outcomes with the use of stent-supported angioplasty in the treatment of symptomatic chronic mesenteric ischemia (CMI). The present study is a retrospective analysis of 36 patients undergoing endovascular treatment of symptomatic CMI, between November 2000 and September 2009. Primary study endpoints were defined as primary patency, periprocedural and midterm mortality and complications, and symptom improvement after intervention. Forty-one mesenteric arteries (77.3% stenotic and 22.7% occluded vessels) were treated in 36 patients with 42 stents. In 30 patients (83.3%) one visceral artery and in 6 cases (16.7%) two visceral arteries were treated. Overall mortality was 16.7% (n=6) after a 60-month follow-up (mean follow-up period 30.1 months). Two early (&lt;30-day) deaths were caused by visceral ischemia (n=2: 5.5%). Late death was procedure-related in one patient with re-occlusion of the superior mesenteric artery after 12 months. The other 3 patients died from non procedure-related causes; e.g. twice myocardial infarction. Initial symptom relief was observed in 29 patients (80.5%); 7 patients reported no change. Primary patency was 83.3% after 5 years and secondary patency was 90.5% (38 out of 42 stents) among all patients. Two conversions to open surgery were documented. First-line endovascular approach of CMI is a reasonable strategy. Close follow-up is mandatory due to symptom recurrence and restenosis.


2013 ◽  
pp. 429-434
Author(s):  
Jan A. Vos ◽  
Jean Paul P. M. de Vries ◽  
Marco J. L. van Strijen

2019 ◽  
Vol 24 (3) ◽  
pp. 216-223 ◽  
Author(s):  
Fabio V Lima ◽  
Dhaval Kolte ◽  
David W Louis ◽  
Kevin F Kennedy ◽  
J Dawn Abbott ◽  
...  

There are limited contemporary data on readmission after revascularization for chronic mesenteric ischemia (CMI). This study aimed to determine the rates, reasons, predictors, and costs of 30-day readmission after endovascular or surgical revascularization for CMI. Patients with CMI discharged after endovascular or surgical revascularization during 2013 to 2014 were identified from the Nationwide Readmissions Database. The rates, reasons, length of stay, and costs of 30-day all-cause, non-elective, readmission were determined using weighted national estimates. Independent predictors of 30-day readmission were determined using hierarchical logistic regression. Among 4671 patients with CMI who underwent mesenteric revascularization, 19.5% were readmitted within 30 days after discharge at a median time of 10 days. More than 25% of readmissions were for cardiovascular or cerebrovascular conditions, most of which were for peripheral or visceral atherosclerosis and congestive heart failure. Independent predictors of 30-day readmission included non-elective index admission, chronic kidney disease (CKD), and discharge to home healthcare or to a skilled nursing facility. Revascularization modality did not independently predict readmission. In a nationwide, retrospective analysis of patients with CMI undergoing revascularization, approximately one in five were readmitted within 30 days. Predictors were largely non-modifiable and included non-elective index admission, CKD, and discharge disposition.


2017 ◽  
Vol 10 (23) ◽  
pp. 2440-2447 ◽  
Author(s):  
Fabio V. Lima ◽  
Dhaval Kolte ◽  
Kevin F. Kennedy ◽  
David W. Louis ◽  
J. Dawn Abbott ◽  
...  

2006 ◽  
Vol 32 (3) ◽  
pp. 304-309 ◽  
Author(s):  
Philipp J. Schaefer ◽  
Fritz K. W. Schaefer ◽  
Stefan Mueller-Huelsbeck ◽  
Thomas Jahnke

2018 ◽  
Vol 19 (2) ◽  
pp. 124-129
Author(s):  
Mohamed Ismail ◽  
Ramez Mounir Wahba ◽  
Atef Abd Elhameed

2017 ◽  
Vol 4 (8) ◽  
pp. 2836
Author(s):  
Harilal V. Nambiar ◽  
Robin George Manappallil ◽  
Sylesh Aikot ◽  
Pramod V.

Chronic mesenteric ischemia is a rare and life-threatening condition which occurs due to occlusion of two or more mesenteric arteries following atherosclerosis. Multi-vessel revascularization forms the mainstay of treatment. This is a case of a middle-aged smoker who presented with abdominal angina and was diagnosed to have chronic mesenteric ischemia due to atherosclerotic occlusive aortic disease with coeliac artery and superior mesenteric artery occlusion. He was successfully managed with extra anatomic bypass from the ascending aorta to superior mesenteric and hepatic artery.


Sign in / Sign up

Export Citation Format

Share Document